Cystic Fibrosis

Thursday 5th december
10.45 - 12.15 h.
Room C3

Magali Reyes Apodaca

627/428 Anthropometric and lung function modifications in patients with cystic fibrosis from a pediatric hospital in Buenos Aires treated with highly effective CRFT Modulators.

627/147 "Survey insights: Challenges and successes of cystic fibrosis care in Latin America".

627/28 UTILIZING THE TRINETX INTERNATIONAL DATABASE OF RARE DISEASE: GI MANIGESTATIONS IN CHILDREN AND YOUNG ADULTS WITH CYSTIC FIBROSIS IN THE PRE AND POST HIGHLY EFFECTIVE TRIPLE MODULATOR THERAPY ERA

The Impact of CFTR Modulators on gastrointestinal symptomatology

Meghana Sathe

Redefining liver disease in CF: new guidelines and definitions

Simon Ling

The pancreas and liver in cystic fibrosis-related disorders

Michael Wilschanski